Therapieoptionen bei aromataseinhibitorassoziierten ArthralgienTreatment Options for Aromatase Inhibitor-Associated Arthralgia

被引：0
|
作者：
Petra Stute
机构：
[1] Inselspital Bern,Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin, Universitätsklinik für Frauenheilkunde
来源：
Journal für Gynäkologische Endokrinologie/Schweiz | 2019年 / 22卷 / 2期
关键词：
D O I：
10.1007/s41975-019-0093-1
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：85 / 86
页数：1
相关论文
共 50 条
  • [31] Aromatase Inhibitor-Associated Musculoskeletal Symptoms: Etiology and Strategies for Management
    Henry, N. Lynn
    Giles, Jon T.
    Stearns, Vered
    ONCOLOGY-NEW YORK, 2008, 22 (12): : 1401 - 1408
  • [32] Practical guidance for the management of aromatase inhibitor-associated bone loss
    Hadji, P.
    Body, J. -J.
    Aapro, M. S.
    Brufsky, A.
    Coleman, R. E.
    Guise, T.
    Lipton, A.
    Tubiana-Hulin, M.
    ANNALS OF ONCOLOGY, 2008, 19 (08) : 1407 - 1416
  • [33] Genetic variation in CYP19A1 and interleukin-6 and aromatase inhibitor-associated arthralgia in breast cancer survivors.
    Mao, J.
    Su, I.
    Feng, R.
    Desai, K.
    Horn, M.
    Chan, D.
    DeMichele, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management
    Hyder, Tara
    Marino, Christopher C.
    Ahmad, Sasha
    Nasrazadani, Azadeh
    Brufsky, Adam M.
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [35] Aromatase inhibitor-associated musculoskeletal pain: An overview of pathophysiology and treatment modalities
    Grigorian, Nelly
    Baumrucker, Steven J.
    SAGE OPEN MEDICINE, 2022, 10
  • [36] Association of Aromatase Inhibitor-Associated Musculoskeletal Symptoms with Ultrasonographic Changes at the Wrist
    Henry, N. L.
    Jacobson, J.
    Banerjee, M.
    Hayden, J.
    Smerage, J.
    Stearns, V
    Hayes, D. F.
    CANCER RESEARCH, 2009, 69 (24) : 527S - 527S
  • [37] Randomized Controlled Trial of a Home-Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors
    Nyrop, Kirsten A.
    Callahan, Leigh F.
    Cleveland, Rebecca J.
    Arbeeva, Liubov L.
    Hackney, Betsy S.
    Muss, Hyman B.
    ONCOLOGIST, 2017, 22 (10): : 1238 - 1248
  • [38] Pilot study of duloxetine for treatment of aromatase inhibitor-associated musculoskeletal symptoms
    Henry, N. Lynn
    Banerjee, Mousumi
    Wicha, Max
    Van Poznak, Catherine
    Smerage, Jeffrey B.
    Schott, Anne F.
    Griggs, Jennifer J.
    Hayes, Daniel F.
    CANCER, 2011, 117 (24) : 5469 - 5475
  • [39] Pharmacogenomics of aromatase inhibitor associated arthralgia in patients with ER plus breast cancer
    Borrie, A. E.
    Teft, W. A.
    Kim, R. B.
    ANNALS OF ONCOLOGY, 2017, 28
  • [40] Molecular basis of aromatase inhibitor associated arthralgia: known and potential candidate genes and associated biomarkers
    Borrie, Adrienne E.
    Kim, Richard B.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (02) : 149 - 156
12345